{"url_path":"/sec/ixhl/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","accession_number":"0001213900-26-057227","cik":"0001873875","ticker":"IXHL","issuer_name":"Incannex Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","primary_entity_key":"0001873875","primary_entity_name":"Incannex Healthcare Inc."},"word_count":88,"has_tables":true,"body_markdown":"Item\n1. Legal Proceedings\n\n \n\nFrom\ntime to time, we may become involved in litigation or other legal proceedings arising in the ordinary course of our business. We and\nour subsidiaries are not currently a party to any material litigation or legal proceedings that, in the opinion of our management, are\nlikely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because\nof defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors."}